Why the study?
Patients with end-stage renal disease undergoing dialysis are at high risk of sudden cardiac death, but no therapy has been shown to reduce this risk and the value of prophylactic ICDs remains uncertain.
Does prophylactic implantable cardioverter-defibrillator therapy reduce sudden cardiac death in patients on dialysis with LVEF ≥35%?
Population
188 dialysis patients with left ventricular ejection fraction ≥35%
Comparison
Prophylactic ICD implantation vs control
Design
Prospective randomized controlled trial
Follow-up
Median 6.8 years
Authors
Loading...
Prophylactic ICDs do not reduce SCD in dialysis patients; leaves open optimal prevention strategies in this high-risk population.
Does prophylactic implantable cardioverter-defibrillator therapy reduce sudden cardiac death in patients on dialysis with LVEF ≥35%?
In patients on dialysis with LVEF ≥35%, prophylactic ICD implantation did not reduce sudden cardiac death or all-cause mortality and was associated with significant device-related complications.
Jukema et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: